Intermediate clinical outcomes | Number, N | Average cluster size | Mean (SD) or n (%) | ICC | 95% CI |
---|---|---|---|---|---|
T2D PATIENTS WITH OR WITHOUT HYPERTENSION (N = 6722) | |||||
 HbA1c, % | 6208 | 155 | 8.3 (2.2) | 0.02 | 0.01, 0.03 |
 HbA1c ≤ 7% | 6208 | 155 | 2135 (34.4) | 0.01 | 0.002, 0.02 |
 HbA1c ≤ 8% | 6208 | 155 | 3291 (53.0) | 0.01 | 0.002, 0.02 |
 Systolic BP, mmHga | 6712 | 168 | 137.8 (17.1) | 0.08 | 0.06, 0.13 |
 Diastolic BP, mmHga | 6712 | 168 | 77.8 (9.8) | 0.08 | 0.05, 0.12 |
 BP ≤ 130/80 mmHg | 6712 | 168 | 1936 (28.8) | 0.09 | 0.05, 0.13 |
 BP ≤ 135/75 mmHg | 6712 | 168 | 1757 (26.2) | 0.06 | 0.03, 0.09 |
 BP ≤ 140/80 mmHg | 6712 | 168 | 2991 (44.6) | 0.08 | 0.05, 0.12 |
 Serum creatinine (μmol/L) | 6455 | 162 | 88.6 (69.7) | 0.01 | 0.01, 0.02 |
 TC (mmol/L) | 6360 | 159 | 5.1 (1.2) | 0.03 | 0.02, 0.06 |
 LDL-C (mmol/L) | 5624 | 141 | 3.0 (1.1) | 0.03 | 0.02, 0.05 |
 LDL-C ≤ 2.6 mmol/L | 5624 | 141 | 2191 (39.0) | 0.02 | 0.01, 0.03 |
 HDL-C (mmol/L) | 5492 | 141 | 1.3 (0.4) | 0.03 | 0.02, 0.05 |
 Triglycerides (mmol/L) | 6335 | 159 | 1.8 (1.2) | 0.01 | 0.01, 0.03 |
PATIENTS WITH HYPERTENSION (N = 5014) | |||||
 Systolic BP, mmHga | 5004 | 126 | 137.8 (17.0) | 0.08 | 0.05, 0.13 |
 Diastolic BP, mmHga | 5004 | 126 | 78.7 (10.9) | 0.09 | 0.06, 0.14 |
 BP < 140/90 mmHg [15] | 5004 | 126 | 2644 (52.8) | 0.05 | 0.02, 0.07 |
 Serum creatinine (μmol/L) | 4738 | 119 | 83.2 (64.6) | 0.01 | 0.01, 0.03 |
 TC (mmol/L) | 4679 | 117 | 5.3 (1.1) | 0.03 | 0.02, 0.06 |
 LDL-C (mmol/L) | 3800 | 95 | 3.2 (1.0) | 0.05 | 0.03, 0.09 |
 LDL-C ≤ 2.6 mmol/L | 3800 | 95 | 1082 (28.5) | 0.03 | 0.01, 0.05 |
 HDL-C (mmol/L) | 3653 | 94 | 1.4 (0.4) | 0.03 | 0.01, 0.05 |
 Triglycerides (mmol/L) | 4685 | 118 | 1.5 (0.9) | 0.01 | 0.004, 0.02 |